Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

Provider 1114159902

NPI: 1114159902Share
Active Billing Period:2018-012023-03(61 months)
Billing appears to have stoppedLast active: 2023-03

Total Paid

$15.8M

$15,766,517

Total Claims

102K

Beneficiaries

3,074

33.1 claims/patient

Avg Cost/Claim

$155

Monthly Spending Trend

Yearly Spending

2018
$2.2M
+184%
2019
$6.3M
-84%
2020
$1.0M
+246%
2021
$3.5M
-34%
2022
$2.3M
-81%
2023
$449K

Procedure Breakdown

Cost per claim compared to national benchmarks

This provider bills for 4 distinct procedure codes. The top code (T2046 (Habilitation, residential, waiver; per month)) accounts for 83% of total spending.

T2046Normal range

Habilitation, residential, waiver; per month

$13.1M

82K claims · 83.3%

Your Cost: $160.04/claim|Median: $1,795.74
0.1× median
T2042Normal range

Financial management, self-directed, waiver, per month

$1.5M

12K claims · 9.6%

Your Cost: $128.00/claim|Median: $188.03
0.7× median
Q5003Normal range

Injection, infliximab-dyyb, biosimilar, 10 mg

$611K

5,671 claims · 3.9%

Your Cost: $107.71/claim|Median: $177.99
0.6× median
Q5004Normal range

$512K

2,347 claims · 3.2%

Your Cost: $217.97/claim|Median: $127.12
1.7× median